http://web.archive.org/web/20150720130831id_/http://www.dailymail.co.uk/news/article-2992726/FDA-decides-suicide-warning-packaging-anti-smoking-drug-Chantix-warns-change-way-people-react-alcohol.html

the @entity0 is keeping a bold - letter warning on @entity2 's anti-smoking drug chantix about suicidal behavior and other psychiatric side effects , after reviewing company findings suggesting the drug does not increase those problems			1
the twice - a - day tablet has carried the @entity0 's strongest warning label since 2009 , following reports of suicidal tendencies and violent or bizarre behavior among some patients			1
the @entity0 on monday outlined several updates to @entity16 's labeling , including a new warning about its potential interaction with alcohol			1
some patients have reported unusual or aggressive behavior when drinking while on @entity16			1
caution : anti-smoking drug @entity16 has carried the @entity0 's strongest warning label since 2009 , following reports of suicidal tendencies and violent or bizarre behavior among some patients ' the @entity0 ( @entity0 ) is warning that the prescription smoking cessation medicine @entity16 ( varenicline ) can change the way people react to alcohol , ' the agency said			1
' in addition , rare accounts of seizures in patients treated with @entity16 have been reported			0
we have approved changes to the @entity16 label to warn about these risks			0
until patients know how @entity16 affects their ability to tolerate alcohol , they should decrease the amount of alcohol they drink			0
patients who have a seizure while taking @entity16 should stop the medicine and seek medical attention immediately			0
' the updated labeling also includes information from several studies and analyses conducted by @entity2 that found no difference in psychiatric problems between people taking @entity16 and other stop - smoking treatments			0
' these studies did not show an increased risk of neuropsychiatric side effects with @entity16 ; however , they did not examine all types of neuropsychiatric side effects , and they had limitations that prevented us from drawing reliable conclusions , ' the @entity0 said			2
last year @entity2 proposed that the @entity0 remove @entity16 's so - called black box warning based on the company 's findings and other data			2
warning : the @entity0 on monday outlined several updates to @entity16 's labeling , including a new warning about its potential interaction with alcohol			1
some patients have reported unusual or aggressive behavior when drinking while on @entity16 the agency 's update follows the recommendation of a panel of outside experts , who voted last october to keep the boxed warning on the drug until it can be reevaluated based on new information			1
@entity82 - based @entity2 is expected to complete a larger study of @entity16 's psychiatric side effects in late 2015			1
@entity16 's safety has been debated in medical journals and courtrooms since 2007 , when reports of suicide , agitation and other problems first began streaming into the @entity0			2
the drug 's labeling currently tells patients to stop taking @entity16 immediately if they experience agitation , depressed mood , suicidal thinking and other behavioral changes			2
doctors are advised to weigh the drug 's risks against its potential benefits of helping patients quit smoking			0
@entity2 's drug works by binding to the same spots in the brain that are activated by nicotine when people smoke			0
the drug , known generically as varenicline , blocks nicotine from binding to those spots and prevents the release of ' feel - good ' brain chemicals that make smoking so addictive .			0

the @entity0 is keeping a bold - letter warning on @entity2 's anti-smoking drug chantix about suicidal behavior and other psychiatric side effects
the tablet has carried the @entity0 's strongest warning label since 2009
that followed reports of suicidal tendencies and violent or bizarre behavior among some patients
the @entity0 on monday outlined several updates to @entity16 's labeling , including a new warning about its potential interaction with alcohol
some patients have reported unusual or aggressive behavior when drinking while on @entity16

@entity2:Pfizer
@entity82:New York
@entity0:FDA
@entity16:Chantix